View by year


CONTENTS 2006
We have organized the Content Archive by year. Each year’s list contains all the articles published in that year, organized by category (i.e., Articles, Buzz, Data Mining, Focal Point, Mayday, Recapping The Week, School Zone, Signals vs. Noise, Turn Signals and Trivia). To search by year, click the appropriate link on the left.

Articles Buzz Focal Point Data Mining Mayday
Recapping The Week School Zone Signals vs Noise Turn Signal Trivia

Articles

12/13/2006Bridging The Gap
By awarding grants for early-stage research on new drugs to treat underserved diseases, non-profit foundations fill the financing gap between government support and venture capital.


10/31/2006The Shell Game
Beloved by con artists for centuries, the shell game is a quick way to separate a man from his money. In the world of high finance, reverse mergers of private firms into public shell outfits used to be considered sleazy, too – but today these deals represent a bona fide way to go public.


9/28/2006Rich Harvest Of New Medicines
This year’s crop of new medicines already contains some blue-ribbon winners – and the harvest is yet complete.


8/07/2006The Yin & Yang Of Bone Health
Our bones are in a constant state of remodeling, and the bone-building and bone-removal processes work in concert. But this balance is disrupted in diseases like osteoporosis and some cancers. New drugs aim to restore the equilibrium.


6/09/2006Big Biotechs Venture Forth
Like their big pharma counterparts before them, some of the biotech sector’s largest and oldest firms have formed venture capital units to explore new opportunities in cutting-edge technologies and next-generation therapies.


4/28/2006Cancer Vaccines’ Bumpy Road
Companies have spent decades trying to develop effective cancer vaccines, but it’s been a difficult job. Finally, however, the tide seems to be turning, and several vaccines could be approved in the near future.


3/15/2006M&As Were Hot In 2005
2005 was a very active year for mergers and acquisitions in the life sciences. Not only were there loads of inter-biotech deals, but big pharma outdid itself, snatching up about four times more biotech firms than usual.


2/04/2006Designer Organisms
If naturally occurring biological systems can’t make the particular biochemical compound or protein you want, why not design synthetic parts to do the task?

top

Buzz

11/27/2006Global Aid From Presidents & Billionaires

10/05/2006Gearing Up For Bio-Generics

6/27/2006Cancer Drugs In The Spotlight

4/12/2006The Five Best Deals

2/15/2006Partnering Deals: Watch Those Milestones

1/06/2006Beaucoup Bucks In ‘05
top

Focal Point

12/20/2006ASH Roundup

10/23/2006Was It Just A Summer Slump?

8/22/2006TNF Blockers Are Top-Sellers

6/19/2006All Aboard, VCs

4/08/2006Financing Off To a Good Start

3/17/2006The Team That Plays Together Stays Together

1/26/2006JPMorgan Conference Kicks Off 2006

1/03/2006No Slow-Down At FDA
top

School Zone

5/24/2006IPOs Reward Academic Researchers And Universities

3/23/2006The Path To Success
top

Signals vs Noise

10/10/2006Financial Snapshot For September 2006: Stocks Hold Their Own

7/14/2006Financial Snapshot For June 2006: Bobbing Along

4/19/2006Financial Snapshot For March 2006: Modest Gains, Solid Quarter

1/18/2006Financial Snapshot For December 2005: Smaller Stocks Need To Catch Up
top

Turn Signals

11/16/2006Divining The Future

10/05/2006The Bio-Generic Regulatory Debate

7/22/20062006: Two Shiny Quarters

5/19/2006Pandemic Flu Vaccines Get Big Boost

2/23/2006Billion Dollar Babies

1/12/2006Bulls And Bears
top

Trivia

12/27/2006Christmas Plant

12/20/2006PCR

12/13/2006CF Gene

12/06/2006Tikvah Therapeutics

11/29/2006Bacterial Genome

11/22/2006Strata

11/15/2006MolecuRx

11/08/2006Rain Forest

11/01/2006Merlion

10/25/2006Trubion

10/18/2006Kythera

10/11/2006First Protein

10/04/2006Brain Map

9/27/2006Millennium IPO

9/20/2006Flies

9/13/2006FDA Authority

9/06/2006Allergies

8/30/2006Lifespan

8/23/2006Acologix

8/16/2006AIDS

8/09/2006BIO 2006

8/02/2006Sweet

7/26/2006Yeast

7/19/2006Reg. FD

7/12/2006Adnectin

7/05/2006Lock-Up

6/28/2006Merck

6/21/2006MedImmune

6/14/2006Opsona

6/07/2006Pony Up

5/31/2006First Insulin

5/24/2006Barbiturates

5/17/2006Synovics

5/10/2006First MAb

5/02/2006Hemophilia

4/26/2006SEC

4/19/2006Smallpox

4/12/2006Smelly

4/05/2006Willow

3/29/2006Vitamin C

3/22/2006Acologix

3/15/2006Sunesis

3/08/2006Old Ancestor

3/01/2006Conatus

2/22/2006First Blockbuster

2/15/2006FBI

2/08/2006Asthma

2/01/2006Vaccination

1/25/2006Oxytocin

1/18/2006Cerimon

1/11/2006Interneuron

1/04/2006Green Peace
top


Copyright © 2012. Signals (signalsmag.com) is an online magazine of analysis for biotechnology executives. To contact the Signals editorial department, send e-mail to signals_edit@deloitte.com. Signals is published by: Recap, 2033 N Main Street, Suite 1050 , Walnut Creek, California 94596-3722, Phone: (925) 952-3870